On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
ThursdayAug 10, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Intent for Human Clinical Study for Diabetes and Weight Loss Following Positive DehydraTECH(TM)-CBD Results in Animals

Lexaria’s patented DehydraTECH(TM)-CBD achieved promising results for diabetes control and weight loss in animals during the pre-clinical animal study DIAB-A22-1 The weight loss drug market was valued at $1.90 billion in 2021 and is expected to reach $13.26 billion by 2029, growing at a CAGR of 24.7% Many drugs used to control diabetes have produced results in managing obesity, which Lexaria plans to leverage with its DehydraTECH(TM) technology Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, recently announced its intent to conduct a human clinical study to examine its patented DehydraTECH(TM)-processed cannabidiol (“CBD”) for diabetes control…

Continue Reading

WednesdayAug 09, 2023 9:45 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) CEO Addresses Critical Minerals Institute Summit II

Ucore is engaged in the exploration for and separation and scalable production of REEs in Canada and the US Ucore Chairman and CEO Pat Ryan recently presented at the Critical Minerals Institute Summit II, where he discussed the risk mitigation strategies Western countries could execute to disrupt China’s dominance in the REE space On its part, and having identified has identified the need and demand for US-based REE refining and processing facilities, Ucore is working on developing, upscaling, and commercializing RapidSX(TM) RapidSX(TM) is the company’s transformative advanced column-based solvent extraction technique for separating both light and heavy REEs; it offers…

Continue Reading

WednesdayAug 09, 2023 9:00 am

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Announces Strategic Steps in Fulfilling Mission to Supply Metals to NA Markets

“Milestone” uplisting gives company greater access, exposure to the crucial U.S. investment market The uplisting has drawn increased focus, credibility to company’s two flagship projects Partnership with IBN designed to strengthen First Tellurium’s presence in growing essential metals market First Tellurium (CSE: FTEL) (OTCQB: FSTTF) is taking key steps that reflect its growth and commitment to explore for — and provide — green and critical metals. Most recently the company announced that it had uplisting to the OTCQB venture market (https://ibn.fm/ZNYik) and had partnered with a veteran corporate communications consulting firm to strengthen the company’s news dissemination (https://ibn.fm/yE468). Upgrading to OTCQB will…

Continue Reading

TuesdayAug 08, 2023 9:45 am

GEMXX Corp. (GEMZ) Announces Significant Progress Regarding Financing for Gold and Ammolite Mining Operations

The company offers an approach that gives them a cost-saving edge over other producers in the market Preliminary discussions have been made to shortlist engineering firms capable of conducting the necessary SK-1300 technical reports for the company’s newest gold and Ammolite assets – with anticipated completion by the end of FY-2023 GEMXX is participating in Regulation A financing, and interested investors, shareholders, institutions, and financiers, are urged to visit the company’s website for more information GEMXX (OTC: GEMZ), a mine-to-market enterprise specializing in gold, gemstone, and jewelry production, recently announced that it has made significant progress in its efforts to…

Continue Reading

TuesdayAug 08, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Celebrates ‘Strategically Important’ New Patent Granted in the US

Lexaria recently celebrated the receipt of its 35th overall granted patent worldwide when the USPTO recently awarded US patent #11,700,875, titled “Compositions and Methods For Sublingual Delivery of Nicotine” The company described the new patent as “strategically important” The patent positions the company to tap into the growing oral nicotine market and offers protection in one of the world’s leading oral nicotine markets This patent could also lead to additional subsequent patents from within this family Lexaria’s DehydraTECH-nicotine formulation is patent granted for oral nicotine delivery in the US, Canada, and Australia When Lexaria Bioscience (NASDAQ: LEXX), a global innovator…

Continue Reading

MondayAug 07, 2023 10:30 am

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Equips Users with Scalable Access to Cashless Alternatives Amid Boom in Digital Payments

FEXD understands the changing dynamics and the growing preference for digital payments Through its aggressive yet strategic acquisition approach, FEXD is offering solutions that make it easy to move money across borders By prioritizing developing nations and creating systems and infrastructure unique to the needs of customers in these countries, FEXD is addressing the issue of gross unmet mobile needs This reflects the company’s commitment to its mission and to creating shareholder value Fintech Ecosystem Development (NASDAQ: FEXD), a special purpose acquisition company (“SPAC”), is focused on the changing consumer landscape and how digital payments are shaping the way people…

Continue Reading

MondayAug 07, 2023 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Collaboration with VINCI Energies and QuantumBasel to Develop Quantum-Hybrid Applications for Industrial Construction

D-Wave, VINCI Energies, and QuantumBasel’s work will include using D-Wave’s annealing quantum computers and quantum hybrid solvers to create a series of quantum-hybrid applications VINCI Energies is exploring the capabilities of quantum computing over classical computing methods for building heating, ventilation, and air conditioning (“HVAC”) system design D-Wave’s Leap(TM) quantum cloud service delivers immediate, real-time access to the company’s Advantage(TM) Quantum Computer and quantum hybrid solver service, with enterprise-class performance and scalability D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, focused on delivering customer value via practical quantum applications, has announced a collaboration with QuantumBasel and…

Continue Reading

MondayAug 07, 2023 9:00 am

Electronic Servitor Publication Network Inc. (XESP) Taps into Growth in Conversational Commerce Market

XESP’s Digital Engagement Engine(TM), uses smart technology to manage meaningful online interactions clients have with their target market The technology tailors content and dynamically connects to an audience in a way that was previously only possible through face-to-face interactions Recent published report indicates that the future of marketing is conversational and that spending on conversational commerce channels is projected to grow to almost $300 billion by 2025, up from $41 billion in 2021 The future of marketing is conversational, according to a recent State of Conversational Commerce Report. The report, which surveyed 8,000 consumers from Australia, Canada, the US, and…

Continue Reading

FridayAug 04, 2023 9:45 am

Sharing Services Global Corp. (SHRG) Subsidiary Celebrates Inaugural Venture Trip as Travel Projected to Grow

Forbes reports that “2023 travel trends show no slowdown” SHRG’s MyTravelVentures offers members full access to exclusive deals across the travel industry The company just wrapped up an exclusive premium resort getaway to Cancun, Mexico As travel spending continues to trend upward, Sharing Services Global (OTCQB: SHRG) wholly owned subsidiary, MyTravelVentures, celebrated a milestone: the company just completed its first-ever Venture Trip at the Sensira Resort and Spa in Cancun, Mexico (https://ibn.fm/61KkX). MyTravelVentures is a subscription-based travel company that offers access to wholesale travel savings, and the company is looking to strengthen its position as the travel space grows. According to…

Continue Reading

FridayAug 04, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Incorporates New Subsidiary, Lexaria Nutraceutical Corp., for Non-Pharmaceutical, Non-Nicotine, and Non-Cannabis DehydraTECH(TM) Formulations

Lexaria Nutraceutical Corp. will keep Lexaria’s overall strategy of maximizing the company’s patented DehydraTECH(TM) technology in various markets, excluding pharmaceutical, nicotine, and cannabis molecules Lexaria Pharmaceutical Corp.’s licensing was amended so as to solely focus on pharmaceutical formulations excluding nicotine Lexaria announced in early May that its nicotine trial, NIC-H22-1, had completed dosing with results expected in the near future NIC-H22-1 is anticipated to intercede the oral nicotine pouch market, which had a global value of $2.33 billion in 2020, and is expected to grow to $21.84 billion by 2027 Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered